Evidence map›Paper›PMID 26214589›Full record

ArticleNature genetics2015

Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.

Thomas G P Grünewald, Virginie Bernard, Pascale Gilardi-Hebenstreit, Virginie Raynal, Didier Surdez, Marie-Ming Aynaud, Olivier Mirabeau, Florencia Cidre-Aranaz, Franck Tirode, Sakina Zaidi and 22 more

Abstract read
In one paragraph

Article in Nature genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Germline Variation and Somatic Alterations in Ewing Sarcoma.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Ewing Sarcoma in the Pediatric Population: Predictors of Survival Within the United States.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2024
    Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors.

Thomas G P GrünewaldGenetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.
Virginie BernardInstitut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, Paris, France.
Pascale Gilardi-HebenstreitÉcole Normale Supérieure (ENS), Institut de Biologie de l'ENS (IBENS), INSERM U1024, CNRS UMR8197, Paris, France.
Virginie RaynalGenetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.
Didier SurdezGenetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.
Marie-Ming AynaudGenetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.
Olivier MirabeauGenetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.
Florencia Cidre-AranazInstituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
Franck TirodeGenetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.ORCID http://orcid.org/0000-0003-4731-7817
Sakina ZaidiGenetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.
Gaëlle PerotINSERM U916 Biology of Sarcomas, Institut Bergonié, Bordeaux, France.
Anneliene H JonkerGenetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.
Carlo LucchesiGenetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.
Marie-Cécile Le DeleyDépartement d'Epidémiologie et de Biostatistiques, Institut Gustave Roussy, Villejuif, France.
Odile OberlinDépartement de Pédiatrie, Institut Gustave Roussy, Villejuif, France.
Perrine Marec-BérardInstitute for Pediatric Hematology and Oncology, Leon-Bérard Cancer Center, University of Lyon, Lyon, France.
Amélie S VéronINSERM U1052, Léon-Bérard Cancer Centre, Cancer Research Center of Lyon, Lyon, France.
Stephanie ReynaudUnité Génétique Somatique (UGS), Institut Curie Centre Hospitalier, Paris, France.
Eve LapoubleUnité Génétique Somatique (UGS), Institut Curie Centre Hospitalier, Paris, France.
Valentina BoevaINSERM U900, Bioinformatics, Biostatistics, Epidemiology and Computational Systems Biology of Cancer, Institut Curie Research Center, Paris, France.
Thomas Rio FrioInstitut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, Paris, France.
Javier AlonsoInstituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0002-6287-8391
Smita BhatiaInstitute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama, Birmingham, Alabama, USA.
Gaëlle PierronUnité Génétique Somatique (UGS), Institut Curie Centre Hospitalier, Paris, France.
Geraldine Cancel-TassinCentre de Recherche sur les Pathologies Prostatiques (CeRePP)-Laboratory for Urology, Research Team 2, UPMC, Hôpital Tenon, Paris, France.
Olivier CussenotCentre de Recherche sur les Pathologies Prostatiques (CeRePP)-Laboratory for Urology, Research Team 2, UPMC, Hôpital Tenon, Paris, France.
David G CoxINSERM U1052, Léon-Bérard Cancer Centre, Cancer Research Center of Lyon, Lyon, France.
Lindsay M MortonDivision of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, Maryland, USA.
Mitchell J MachielaDivision of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, Maryland, USA.
Stephen J ChanockDivision of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, Maryland, USA.
Patrick CharnayÉcole Normale Supérieure (ENS), Institut de Biologie de l'ENS (IBENS), INSERM U1024, CNRS UMR8197, Paris, France.
Olivier DelattreGenetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.

Funding

Mach-LETSGO: Machine-LEarning of Treatment, Survey, and Genetics towards Obtaining Correct Classification of Chronic Conditions in Adult Survivors in the Childhood Cancer Survivor Study - CCSS SupplU24CA055727 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Gregory Armstrong · 1999 to 2026
$96.7M
NCI NIH HHS U24 CA055727
6 · The paper itself

Abstract

Deciphering the ways in which somatic mutations and germline susceptibility variants cooperate to promote cancer is challenging. Ewing sarcoma is characterized by fusions between EWSR1 and members of the ETS gene family, usually EWSR1-FLI1, leading to the generation of oncogenic transcription factors that bind DNA at GGAA motifs. A recent genome-wide association study identified susceptibility variants near EGR2. Here we found that EGR2 knockdown inhibited proliferation, clonogenicity and spheroidal growth in vitro and induced regression of Ewing sarcoma xenografts. Targeted germline deep sequencing of the EGR2 locus in affected subjects and controls identified 291 Ewing-associated SNPs. At rs79965208, the A risk allele connected adjacent GGAA repeats by converting an interspaced GGAT motif into a GGAA motif, thereby increasing the number of consecutive GGAA motifs and thus the EWSR1-FLI1-dependent enhancer activity of this sequence, with epigenetic characteristics of an active regulatory element. EWSR1-FLI1 preferentially bound to the A risk allele, which increased global and allele-specific EGR2 expression. Collectively, our findings establish cooperation between a dominant oncogene and a susceptibility variant that regulates a major driver of Ewing sarcomagenesis.

Indexed as

AnimalsBase SequenceBone NeoplasmsCarotenoidsCell Line, TumorCell ProliferationEarly Growth Response Protein 2Gene ExpressionGene Expression Regulation, NeoplasticGenetic Association StudiesGenetic Predisposition to DiseaseHumansMice, SCIDMicrosatellite RepeatsMolecular Sequence DataNeoplasm Transplantationbeta-apocarotenoid-14',13'-dioxygenaseCarotenoidsEarly Growth Response Protein 2EGR2 protein, humanEWS-FLI fusion proteinOncogene Proteins, FusionOxygenasesProto-Oncogene Protein c-fli-1RNA-Binding Protein EWS

Identifiers

PMID26214589
PMCPMC4591073

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.